Researchers sought to determine the efficacy of the mRNA-based vaccination against the Omicron variant of COVID-19 in patients with hematologic malignancies.
Overall, 17.7 cases of myocarditis reported per million vaccinations; 77 percent had symptom resolution at time of report.
Researchers evaluated outcomes among patients with mild to moderate COVID-19 infection who received mAb treatment with casirivimab-imdevimab vs sotrovimab.
Rates of concern higher than those of older women or men of any age.
Researchers examined if positive and negative expectations prior to COVID-19 vaccination are associated with adverse effects after receipt of the second vaccine dose.
Parents who are more concerned about long-term risk and report greater anticipated responsibility less likely to vaccinate.
The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the US.
Researchers investigated the disproportionate outcome of the COVID-19 pandemic among residents at long-term care facilities.
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.
Higher rates of vaccination seen in older patients; lower rates seen for metastatic solid tumors, with comorbidities.
